LR Health & Beauty SE Confirms Q3 2025 Results Amid Market Challenges

LR Health & Beauty SE, a leader in digital social commerce, has published its final results for the third quarter of 2025. The company's sales for the nine months reached EUR 208.8 million, and EBITDA stood at EUR 16.3 million. Lower sales and increased marketing costs impacted third-quarter results, with sales dropping to EUR 66.0 million from EUR 69.4 million the previous year. EBITDA in Q3 fell to EUR 2.9 million, down from EUR 7.3 million in the prior year.

Despite weak consumer sentiment, new fragrance collections in September provided a boost. CEO Jörg Körfer remains optimistic, focusing on strengthening the company's financial foundations and competitiveness through strategic initiatives. LR Health & Beauty SE maintains its sales forecast for 2025, expecting revenues between EUR 276 million and EUR 281 million.